Gut Microbiome, Microbial Metabolites and Cardiometabolic Risk

lt;br> Massimo Federici is currently Professor of Medicine and Nutrition at the University of Rome "Tor Vergata" Medical School and Director of the Center for Atherosclerosis at the Tor Vergata Medical School hospital. After a Medical Doctor degree (1994) he trained in Endocrinology and Metabolism at the University of Rome actively working in both clinical and molecular research. After a post-doc at the Joslin Diabetes Research Laboratory at Harvard Medical School in Boston, USA, he returned to Rome to start a new laboratory dedicated to the vascular complications of metabolic diseases. Among the major interests the role of TIMP3 and ADAM17 activation as a mechanism linking insulin resistance, diabetic complications and atherosclerosis. In 2006 he was awarded the Morgagni Prize Silver Award and with the European Association for the Study of Diabetes Rising Star Lecture.
Rossella Menghini is currently Associate Professor of Clinical Biochemistry at the Department of Systems Medicine, University of Rome Tor Vergata. After a Chemistry Bachelor Degree  (1996) she has been research fellow at the Department of Cell and Developmental Biology of the "Sapienza" University of Rome, where she obtained a Board certification in Chemical Science. She has been Visiting Scientist at the Department of Cellular Microbiology and Immunology of the Vienna Biocentrum, Austria. In 2003 she obtained the Ph.D. Degree in Experimental Physiopathology at the University of Rome "Tor Vergata, where from 2033 to 2007 she worked as Postdoctoral Researcher at the Molecular Medicine Laboratory Department of Internal Medicine. 

Methods To Study Metagenomics.- Methods To Study Metabolomics.- Gut Microbiome And Microbial Metabolites.- The Leaky Gut Hypothesis.- Gut Microbiome And Tissue Signature.- Gut Microbiome And Obesity.- Gut Microbiome And Brown Adipose Tissue.- Gut Microbiome And Hepatic Steatosis.- Gut Microbiome And Type 2 Diabetes.- Gut Microbiome And Hypertension.- Gut Microbiome And Dyslipidemia.- Gut Microbiome And Atherosclerosis.- Gut Microbiome And Heart Failure.- Gut Microbiome And Stroke.- Gut Microbiome And Cognitive Functions.- The Other Microbiome: Oral Microbiota And Cardiometabolic Risk.- Prebiotics And Probiotics To Treat Cardiometabolic Risk.- Nutrients, Intestinal Inflammation And Gut Microbiome.